At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Trial to Assess Functional, Microbial, Radiological and Patient Reported Outcomes at Totally Implantable Venous Access Device (Port) Removal (PREMO Study)
In Brief
A clinical study evaluating Evaluation of the catheter function, Catheter tip location, thrombus, sleeve and device damage visualization, and 3 other interventions for Neoplasms and Cystic Fibrosis. Completed, enrolled 100 participants across 1 site.
Detailed Summary
A Totally Implantable Venous Access Device (TIVAD) that is no longer in use for intravenous therapy, should be flushed at established intervals to promote and maintain patency. No consensus has been established regarding the optimal duration of the interval between 2 maintenance sessions. This exploratory study will focus on catheter status under the current 3-monthly flush regimen.
Study Details
Timeline
Interventions
Catheter function will be measured by the CINAS (Catheter injection and aspiration classification)
Catheter tip location, thrombus, sleeve and device damage will be visualized by linogram
TIVAD colonization will be investigated by microbiological culture of the tip and chamber content
PROM will evaluate patient's experiences regarding the TIVAD insertion, dwell time, and removal using the Leuven Patient Reported Experiences at Port removal (Leuven PREP) questionnaire.
Macroscopic evaluation of the port chamber and catheter will be performed after port removal.